Back to Search Start Over

Anxiety among hospitalized COVID-19 patients: a case-control study from a tertiary teaching hospital in Malaysia.

Authors :
Tan HJ
Shahren AAH
Khoo CS
Ng CF
Zaidi WAW
Kori N
Periyasamy P
Eu CL
Payus AO
Hod R
Source :
Frontiers in psychiatry [Front Psychiatry] 2023 May 18; Vol. 14, pp. 1148019. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Anxiety has been increasingly recognized as part of the psychosocial health issues in COVID-19 patients. However, the impact of this topic may be underestimated in low- and middle-income countries. This study aimed to estimate the prevalence of and risk factors of anxiety in COVID-19 patients compared to controls in a local tertiary teaching hospital in Malaysia.<br />Methods: In this case-control study, we analyzed data on adult patients aged 18 years and above hospitalized for COVID-19 infection with matched hospitalized controls. The demographic, clinical data and anxiety measures using the Generalized Anxiety Disorder-7 questionnaire were analyzed using univariate and multivariate analysis.<br />Results: 86.6% in the COVID-19 group had anxiety, significantly higher than 13.4% in the control group ( p  = 0.001). The COVID-19 group was significantly associated with the GAD-7 severity ( p  = 0.001). The number of COVID-19 patients in the mild, moderate, and severe anxiety groups was 48 (84.2%), 37 (86%), and 18 (94.7%), respectively. Multiple logistic regression showed significant predictors for anxiety, including COVID-19 diagnosis and neurological symptoms. Anxiety was found 36.92 times higher in the patients with COVID-19 compared to those without COVID-19 (OR 36.92;95% CI 17.09, 79.78, p  = 0.001). Patients with neurological symptoms were at risk of having anxiety (OR 2.94; 95% CI 1.03, 8.41, p  = 0.044).<br />Discussion: COVID-19 patients experience a significant disruption in psychosocial functioning due to hospitalization. The burden of anxiety is notably high, compounded by a diagnosis of COVID-19 itself and neurological symptomatology. Early psychiatric referrals are warranted for patients at risk of developing anxiety symptoms.<br />Competing Interests: The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Tan, Shahren, Khoo, Ng, Zaidi, Kori, Periyasamy, Eu, Payus and Hod.)

Details

Language :
English
ISSN :
1664-0640
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in psychiatry
Publication Type :
Academic Journal
Accession number :
37275980
Full Text :
https://doi.org/10.3389/fpsyt.2023.1148019